Explore our blogs on various markets

Market research is the foundation of smart product development. It helps you understand your customers, market gaps, and competitor strategies before investing time or money. . In this guide, you will learn step by step how to do market research for product development...

Market research in retail and eCommerce means collecting, analyzing, and using data to make better business decisions.. It helps retailers and online sellers understand their customers, spot trends, compare competitors, and reduce risks. In fast-moving digital markets, doing good market research is no longer optional; it is essential....

Biosimilars are medicines that are very close to already approved biologic drugs. They are not exact copies, but they work in the same way and are proven safe and effective. Because they cost less than original biologics, biosimilars help reduce healthcare spending and allow more patients to get access to important treatments....

Strategies for Successful Pharma Product Launches. Launching a new pharma product is not easy. It takes years of research, large investments, and strict regulatory approvals...

As of 2024, the global AI in Mental Health market is valued at approximately $2.1 billion, with an impressive CAGR of 7.8%. This growth reflects a rising demand for scalable, technology-driven solutions in an area where access to care remains deeply uneven.  ...

Health equity means everyone gets the care they need to live a healthy life. It means care and medicines reach people no matter their race, age, money, or where they live.. Right now, many people do not get fair care...

Accurate drug demand forecasting is the key to keeping medicines available and avoiding waste. It helps companies plan production, manage supply chains, and meet patient needs on time.. The future of drug demand is shaped by many factors, such as aging populations, new diseases, patent expiries, and personalized medicine...

Beyond Air, Inc. (NASDAQ: XAIR) has submitted a premarket approval (PMA) supplement to the U.S. Food and Drug Administration (FDA) for its second-generation LungFit PH II system....

The U.S. Food and Drug Administration (FDA) has approved BRINSUPRI™ (brensocatib), making it the first and only therapy for non-cystic fibrosis bronchiectasis (NCFB). . This chronic lung disease affects more than 500,000 people in the United States and has long been without an approved treatment option....

Cell and gene therapies (CGTs) represent a new frontier in healthcare. These treatments aim to modify or replace cells and genes to treat or cure diseases that were previously untreatable. . While their promise is enormous, launching them is not simple...

Running oncology clinical trials in the US is complex and resource-heavy. Patient recruitment, biomarker testing, data collection, and regulatory reporting all demand specialized expertise. Pharmaceutical companies and biotech sponsors often rely on Contract Research Organizations (CROs) to manage parts or all of the trial process....

Regulation shapes every part of the pharmaceutical industry. Agencies like the WHO, FDA (US), EMA (EU), MHRA (UK), ANVISA (Brazil), NMPA (China), and CDSCO (India) control how drugs are researched, developed, manufactured, and approved.. In 2025, these authorities are updating their frameworks to keep pace with artificial intelligence, digital health, advanced clinical trial models, sustainability rules, and global supply chain standards....

Pharma companies spend billions every year trying to influence doctors, patients, and healthcare systems. Yet clinical data and product claims alone often fail to change outcomes. People rely on habits, emotions, social cues, and mental shortcuts, not just logic. ...

Vaccines are biological products that protect people from infectious diseases by stimulating the body’s immune system. They are one of the most effective tools in public health, reducing illness, saving lives, and lowering healthcare costs.. The demand for vaccines is increasing worldwide due to government immunization programs, new biotechnology platforms like mRNA, and a growing need to prevent both infectious and chronic diseases....

Pharma R&D efficiency is under constant review by executives, investors, and regulators. The cost of bringing a new drug to market has increased, while success rates in clinical trials remain low. At the same time, pressure from pricing reforms, patent expiries, and investor expectations is forcing companies to do more with less....

Cell and gene therapies are changing modern medicine, offering new hope for patients with cancer, genetic disorders, and rare diseases. However, the success of these treatments depends on reliable and scalable manufacturing. Current processes are often complex, slow, and dependent on manual steps that introduce risks....

Daré Bioscience is set to launch DARE to PLAY™ Sildenafil Cream, the first evidence-backed topical treatment for female sexual arousal, in late 2025. Partnering with Rosy Wellness, the company has begun an awareness campaign to reduce stigma and provide women with trusted education and support around sexual health.. A Major Step Forward in Women’s Health...

Cancer drugs remain among the most expensive medicines in healthcare. While innovative treatments bring hope, their high cost often restricts access for patients and strains health budgets. . Generic oncology drugs, both small-molecule generics and biosimilar,s have emerged as the most powerful tool to improve affordability. ...

Zug, Switzerland (June 26, 2025) – Galderma has announced two new Phase II clinical trials to study nemolizumab, a drug designed to block the IL-31 receptor. . These trials will focus on patients with Systemic Sclerosis (SSc) and Chronic Pruritus of Unknown Origin (CPUO), two conditions with high unmet medical needs and no approved treatments available.. What is Nemolizumab?...

Roche announced significant progress in its Alzheimer’s disease research portfolio during the Alzheimer’s Association International Conference (AAIC) 2025 in Toronto.. The company presented detailed results from its investigational therapy trontinemab and showcased its Elecsys pTau217 blood test, both of which aim to transform the detection and treatment of Alzheimer’s disease.. Advancing trontinemab with Brainshuttle technology...